首页 产品目录 分子砌块 按反应类型 氨基甲酸酯合成 5-((3S,5S,8R,9S,10R,13R,14S,17R)-3,5,14-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2H-pyran-2-one

5-((3S,5S,8R,9S,10R,13R,14S,17R)-3,5,14-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2H-pyran-2-one

5-((3S,5S,8R,9S,10R,13R,14S,17R)-3,5,14-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2H-pyran-2-one

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量
5mg 95% 询价
- +
10mg 95% 询价
- +
25mg 95% 询价
- +
50mg 95% 询价
- +
100mg 95% 询价
- +
250mg 95% 询价
- +
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

472-26-4

英文名称

5-((3S,5S,8R,9S,10R,13R,14S,17R)-3,5,14-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2H-pyran-2-one

别名

3β,5,14-Trihydroxy-5β,14β-bufa-20,22-dienolide;3β,5,14-Trihydroxy-5β-bufa-20,22-dienolide;Telocinobufagin;Telocinobufogenin;(3beta,5beta)-3,5,14-Trihydroxybufa-20,22-dienolide;Telobufotoxin;(3β,5β)-3,5,14-Trihydroxybufa-20,22-dienolide;NSC 119989

标准英文名

5-((3S,5S,8R,9S,10R,13R,14S,17R)-3,5,14-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2H-pyran-2-one

分子式

C24H34O5

分子量

402.53

精确分子量

402.24

SMILES

C[C@]12CC[C@H](O)C[C@@]1(O)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](C3=COC(=O)C=C3)CC[C@]12O

标准SMILES

C[C@]12CC[C@H](O)C[C@@]1(O)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@H](CC[C@@]21O)C1C=CC(=O)OC=1

用途

Telocinobufagin is used for content determination, identification, and pharmacological experiments; it exhibits significant anticancer, cardiotonic, analgesic, antiviral, anesthetic, and bone marrow-stimulating activities; it is clinically applied in the treatment of cancers such as hepatocellular carcinoma, gastric cancer, and esophageal cancer with an efficacy rate of 50–70%; it helps prevent leukopenia induced by radiotherapy and chemotherapy, enhances the therapeutic effects and tolerance to these treatments, and has been formulated into an aerosol for rapid pulmonary absorption with minimal side effects; it also demonstrates potent cardiotonic effects surpassing those of digitalis glycosides and shows antiarrhythmic electrophysiological properties.

InChIKey

PBSOJKPTQWWJJD-ZBDZJSKLSA-N

安全信息

SureRoute逆合成路线

1.  472-26-4 逆合成路线 1

—
—
ACAGTU540
472-26-4
来源: SureRoute

2.  472-26-4 逆合成路线 2

—
—
ACAGTU540
472-26-4
来源: SureRoute

3.  472-26-4 逆合成路线 3

—
—
ACAGTU540
472-26-4
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手